INTRODUCTION

Assessment of intermediate coronary lesions (30-70% stenosis) by coronary angiogram has
been shown to be a poor predictor of the hemodynamic significance of the lesion [1] .
Earlier studies had suggested that fractional flow reserve (FFR)-guided revascularization was superior at reducing major cardiac adverse outcomes when compared with angiogram-guided revascularization [2] [3] [4] . The
5-year follow-up of the Fractional Flow Reserve
Versus Angiography for Multivessel Evaluation (FAME; Clinicaltrials.gov identifier, NCT00267774) trial demonstrated that an FFR-guided approach is associated with a similar risk of major events but with a lower number of stented arteries and less resource use [5] . FFR assessment during coronary angiography is endorsed by the European Society of Cardiology and the American College of Cardiology for identification of hemodynamically significant lesions when non-invasive evidence of myocardial ischemia is unavailable [6, 7] . Deferral of revascularization is recommended for non-ischemic lesions [8, 9] . 
